Eli Lilly raises UK price of weight-loss drug Mounjaro by up to 170%
Pharma group seeks to address US complaints about ‘foreign freeloaders’ who rely on Americans to pay more for medicines
Related reading
UK patients rush to buy obesity jab ahead of 170% price rise
Asda warns of ‘difficult situation’ after US drugmaker Eli Lilly responds to pressure from Donald Trump
Eli Lilly pushes for NHS drug price increases in return for its UK investment
US pharmaceutical group ‘optimistic’ about reaching deal with British government
Eli Lilly shot helped patients lose 29% of body weight
Trial results are a boost to US pharmaceutical company’s booming obesity business
US to slash prices of obesity drugs offered on Trump website
White House’s landmark deal with Novo Nordisk and Eli Lilly will cut costs from at least $1,000 to about $350
Eli Lilly not yet ready to unfreeze UK investments, says pharma boss
US drugmaker wants changes to types of drugs approved in Britain
Triple dose of Novo Nordisk drug delivers 19% weight loss in trials
Danish pharma group seeks to broaden options and stay competitive with Eli Lilly